deferoxamine has been researched along with phytic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bandy, B; Davison, AJ | 1 |
Avenard, G; Chassaigne, M; Girot, R; Hurel, C; Nicolau, C; Ropars, C; Teisseire, B | 1 |
Bandy, B; Davison, AJ; Moon, J; Walter, PB | 1 |
Davidsson, L; Fidler, MC; Hurrell, RF; Walczyk, T | 1 |
Becker, HH; Dopp, E; Lohani, M; Poser, I; Rahman, Q; Schiffmann, D; Weiss, DG; Yadav, S | 1 |
Aust, AE; Baldys, A | 1 |
1 trial(s) available for deferoxamine and phytic acid
Article | Year |
---|---|
Iron absorption from fish sauce and soy sauce fortified with sodium iron EDTA.
Topics: Adult; Anemia, Iron-Deficiency; Biological Availability; Deferoxamine; Diet; Edetic Acid; Female; Ferric Compounds; Ferritins; Fish Oils; Food, Fortified; Glycine max; Humans; Intestinal Absorption; Iron Isotopes; Iron, Dietary; Nutritional Status; Phytic Acid | 2003 |
5 other study(ies) available for deferoxamine and phytic acid
Article | Year |
---|---|
Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: mechanisms by which metal chelation enhances inhibition by superoxide dismutase.
Topics: Adenosine Diphosphate; Catalase; Chelating Agents; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Hydroxydopamines; Ligands; Metals; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Superoxide Dismutase | 1987 |
Improved oxygen delivery to tissues and iron chelator transport through the use of lysed and resealed red blood cells: a new perspective on Cooley's anemia therapy.
Topics: Animals; Blood Transfusion; Chelating Agents; Deferoxamine; Erythrocyte Aging; Erythrocyte Transfusion; Hematopoiesis; Hemoglobins; Iron; Oxygen; Phytic Acid; Swine; Thalassemia | 1985 |
Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis.
Topics: Adenosine Diphosphate; Bromides; Buffers; Catalysis; Copper; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Iron; Ligands; Manganese; Osmolar Concentration; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Sodium Compounds; Thermodynamics; Vanadium | 2001 |
Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor.
Topics: Acetylcysteine; Asbestos, Crocidolite; Asbestos, Serpentine; Chelating Agents; Deferoxamine; Epithelial Cells; Free Radical Scavengers; Humans; Kinetochores; Lysine; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagenesis; Phytic Acid; Superoxide Dismutase; Thiourea | 2004 |
Role of iron in inactivation of epidermal growth factor receptor after asbestos treatment of human lung and pleural target cells.
Topics: Asbestos; Asbestos, Crocidolite; Carcinogens; Cell Line; Cytochalasin B; Cytochalasin D; Deferoxamine; Dose-Response Relationship, Drug; Endocytosis; ErbB Receptors; Humans; Iron; Iron Chelating Agents; Lung; Mineral Fibers; Phosphorylation; Phytic Acid; Receptor, ErbB-2 | 2005 |